Sustained release of prindopril erbumine from its chitosan-coated magnetic nanoparticles for biomedical applications.
about
Comparative Solid-State Stability of Perindopril Active Substance vs. Pharmaceutical Formulation.Improved Anticancer Effect of Magnetite Nanocomposite Formulation of GALLIC Acid (Fe₃O₄-PEG-GA) Against Lung, Breast and Colon Cancer Cells.Nano-Formulation of Ethambutol with Multifunctional Graphene Oxide and Magnetic Nanoparticles Retains Its Anti-Tubercular Activity with Prospects of Improving Chemotherapeutic Efficacy.Release behavior and toxicity profiles towards leukemia (WEHI-3B) cell lines of 6-mercaptopurine-PEG-coated magnetite nanoparticles delivery system.Controlled-release formulation of perindopril erbumine loaded PEG-coated magnetite nanoparticles for biomedical applications
P2860
Sustained release of prindopril erbumine from its chitosan-coated magnetic nanoparticles for biomedical applications.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 03 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Sustained release of prindopri ...... s for biomedical applications.
@en
Sustained release of prindopri ...... s for biomedical applications.
@nl
type
label
Sustained release of prindopri ...... s for biomedical applications.
@en
Sustained release of prindopri ...... s for biomedical applications.
@nl
prefLabel
Sustained release of prindopri ...... s for biomedical applications.
@en
Sustained release of prindopri ...... s for biomedical applications.
@nl
P2093
P2860
P356
P1476
Sustained release of prindopri ...... es for biomedical applications
@en
P2093
Aminu Umar Kura
Dena Dorniani
Mohd Zobir Bin Hussein
Sharida Fakurazi
Zalinah Ahmad
P2860
P304
23639-23653
P356
10.3390/IJMS141223639
P407
P577
2013-12-03T00:00:00Z